Autism and autism-spectrum disorders exhibit high heritability, although specific susceptibility genes still remain largely elusive. We performed a heterogeneity-based genome search meta-analysis (HEGESMA) of nine genome scans on autism or autism-spectrum disorders. Each genome scan was separated in 30 cM bins and the maximum linkage statistic from each bin was ranked. Significance for each bin's average rank and for between-scan heterogeneity (dis-similarity in the average ranks) was obtained through Monte Carlo tests. For autism, data from 771 affected sibpairs were synthesized across six separate genome scans. Region 7q22-q32 reached genome-wide significance both in weighted and unweighted analyses, with evidence for significantly low between-scan heterogeneity. The flanking chromosomal region 7q32-qter reached the less stringent threshold of suggestive significance, with no evidence for low between-scan heterogeneity. For autism-spectrum disorders (634 affected sibpairs from five separate scans), no chromosomal region reached genome-wide significance. However, suggestive significance was reached for the chromosomal regions 17p11.2-q12 and 10p12-q11.1 in weighted analyses. There was evidence for significantly high between-scan heterogeneity for the former region. The meta-analysis suggests that the 7q22-q32 region should be further scrutinized for autism susceptibility genes, while autism-spectrum disorders seem to have quite diverse linkage signals across scans, possibly suggesting genetic heterogeneity across subsyndromes and subpopulations.
Introduction
Autism (MIM 209850) is a pervasive neurodevelopment disease characterized by qualitative impairments in reciprocal verbal communication and social interaction and responsiveness, repetitive stereotyped behaviors and interests, and typically onset in the first 3 years of life. 1, 2 Autism is the most characteristic recognizable syndrome in a wider spectrum of pervasive developmental disorders that also include Asperger syndrome, and pervasive developmental disorder not otherwise specified. There is considerable evidence that autism-spectrum disorders have a strong hereditary component. Concordance in monozygotic twins is 70-90 vs 0-25% among dizygotic twins. [3] [4] [5] [6] The estimated sibling risk is almost 100-fold higher than the population risk. 4, 7, 8 It has been estimated that 10-15 genes may be implicated in the regulation of the complex genetic risk of autism-spectrum disorders. [9] [10] [11] [12] However, the risk is not conferred in a Mendelian fashion and identification of these genes has been hampered further by the probably small population effect sizes of each of them, and the lack of clear pathophysiology hints to suggest particularly strong candidate genes. Therefore, the typical approach to-date has been the performance of genome scans.
A number of such scans has been published in the last decade 9, [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] and many of them have been recently updated, expanded, or elaborated in twostage designs in an effort to generate additional information for specific promising chromosomal regions. Despite some overlap in the findings of these scans, typically each scan has shown little or no evidence for strong linkage signals and the results are generally difficult to interpret. Importantly, each scan performed to-date has had a relatively limited number of affected sibpairs and this has limited the conclusiveness of the inferences. It would thus be interesting to synthesize all the accumulated information across available genome scans and to evaluate the consistency and heterogeneity of the results of different scans. An early effort tried to synthesize data from four genome scans 9, 14, 16, 20 using a meta-analytic methodology. 30 This early meta-analysis used a method that combined P-values across these four scans and arrived at the conclusion that a susceptibility locus was most likely to exist in the 7q area. However, since then, several new genome scans have been published and older scans have been expanded. Thus, a much larger sample size is available for a meta-analysis of the accumulated evidence. Moreover, new methods have been developed for the synthesis and interpretation of information from diverse genome scans on the same disease using genome scan meta-analysis. [31] [32] [33] Recently, it has been shown that evaluation of heterogeneity, that is, the diversity of linkage results across genome scans, is as important as, or even more important than, the simple synthesis of the data. 33 Here, we have applied the new methodology of heterogeneity-based genome search (genome scan) meta-analysis, HEGESMA, to the available genome-wide linkage data on autism-spectrum disorders.
Materials and methods
Search strategy and eligible whole genome scans We searched for eligible whole genome scans on autism-spectrum disorders in PubMED (last search April 2005) using the keywords 'autism', 'Asperger syndrome', 'gene', 'genome search', and 'scan'. We also perused the bibliography of identified pertinent articles and relevant reviews for additional studies. All potentially eligible articles were scrutinized for eligibility and potential overlap of the studied populations. In case of overlap, only the largest study was retained, in order to avoid duplication of data.
Eligible studies were those that had performed whole genome scans either for strictly defined autism or for autism-spectrum disorders using a minimum of 100 microsatellite markers and regardless of the statistical analytical method and software employed. We excluded studies or subsets of subjects thereof where data were derived only for specific chromosomes or specific chromosomal regions. However, we included data where all subjects had been assessed first with a common set of markers, and then some subjects and families were studied in additional genotyping detail as part of a two-stage scan. In these circumstances, we used data from both stages.
Data extraction
For each eligible study, we extracted information on authors, year of publication, recruitment of families, countries of recruitment, diagnostic criteria, and types of autism-spectrum disorder diagnoses included, number of families, probands, and affected sibpairs analyzed, number of microsatellite markers evaluated, whether a one-or two-stage design was employed, the method of the main statistical analysis and the software used. Whenever multiple statistical analyses were available in a study, we generally preferred the results obtained by multipoint MLS.
We communicated with authors of the genome scans to invite them to participate in this effort and to provide detailed data on each genome scan. Whenever such data were not available, genome scan results across each chromosome were derived from published figures showing linkage scores per pter distance in each chromosome. This information was also occasionally complemented by specific data on observed peaks presented in tables and/or text. Figures were electronically digitized using appropriate software (Engauge Digitizer, ver 2.12, Mark Mitchell, 2002) and information about the peaks was read directly across each chromosome, also with corroboration of the readout against available published information in text and tables.
Genome scan meta-analysis and testing and interpretation of between-scan heterogeneity Data were synthesized across genome scans using the genome search (genome scan) meta-analysis, GSMA, method as previously described. 31 In brief, the genome was divided in approximately 30 cM regions (bins). By convention the bins were identified using the chromosome number and the number of the bin in that chromosome. For example, 'bin 7.5' is the fifth bin of the seventh chromosome. We recorded the maximal linkage statistic observed in each of the resulting 119 autosomal regions. These statistics were then ranked according to their magnitude with the highest rank given to the highest value. Negative linkage values were handled as zero. Ties were handled by ascribing the same rank to all bins with tied linkage statistics. A Monte Carlo test was then used to estimate the statistical significance of the summary ranks or average ranks (summary ranks divided by number of scans) for each chromosomal region across all available genome scans according to the GSMA method. 31 A bin that has very high ranks in all searches will tend to have a very high average rank, while a bin with very low ranks in all searches will have a very low average rank. The P ord statistic was also calculated that may provide additional information about linkage. The P ord statistic is the probability to observe the given average rank by chance in bins which occupy that order among Monte Carlo replicates. 34 As we have recently proposed, not only the average rank, but also the heterogeneity between ranks across searches is important to quantify. As previously described, 33 we evaluated three heterogeneity metrics (Q, Ha and B) that capture the diversity in the ranks of each chromosomal region across available searches. The statistical significance of these heterogeneity metrics was tested against Monte Carlo test distributions using permutations of the ranks of each scan and allowing also for ties. 33 Analyses of statistical significance for heterogeneity were performed using two different approaches. 33 One approach estimates whether the observed between-scan heterogeneity is significantly high or significantly low regardless of the observed average rank of the tested chromosomal region. Another approach estimates whether the observed between-scan heterogeneity is significantly high or significantly low after accounting for the observed average rank of the tested chromosomal region. 33 The rationale for this second approach is that the observed heterogeneity metrics may depend on each bin's average rank. It is important to differentiate significantly low between-scan heterogeneity, where genome scans generally agree in the relative rank of a bin, from significantly high between-scan heterogeneity, where a profound disagreement across the synthesized scans exists. Thus, inferences on the presence of either low or high between-scan heterogeneity are based on one-sided tests (left-or right-sided tests, respectively). 33 All Monte Carlo analyses were run with both weighted and unweighted methods. Weighted calculations weighted each scan by the number of affected sibpairs. 31 Furthermore, we performed two sets of analyses. The first set was limited only to strictly defined autism, while the second set included all autism-spectrum disorders.
Formal statistical significance was tested at the a ¼ 0.05 level. Thus, genome-wide significance was tested at P-value=0.00042, after accounting for 119 comparisons. 34 Suggestive linkage refers to the probability to observe a given result once per scan and was tested at the a ¼ 1/119 ¼ 0.0084 level. 34 GSMA and HEGESMA were performed using the HEGESMA software 35 with 10 000 replications. Inferences on the presence of between-scan heterogeneity are leftsided, unless otherwise specified. All other P-values are two-tailed. Handling of HEGESMA output and graphics were performed in Intercooled Stata 8.2 (Stata Corp. College Station, TX, USA).
Results
We identified 17 potentially eligible articles on genome scans that were further scrutinized in fulltext. Of those, we excluded eight because they were either subsets that were fully included in other larger studies 13, 14, 17, 18, 21, 26, 27, 29 or they overlapped partially with larger studies. 17, 27, 29 Thus nine whole genome scans were included in the meta-analysis. The key characteristics of eligible studies are shown in Table  1 . All studies used similar, but not exactly identical, criteria for diagnosis of the conditions of interest, employing different combinations of the Diagnostic and Statistical Manual for Mental Disorders IV (DSM IV) and the International Classification of Diseases 10 (ICD-10) criteria, and the Autism Diagnostic Interview-Revised (ADI-R) and Autism Diagnostic Observation Schedule (ADOS) instruments.
GSMA and HEGESMA -strictly defined autism In the assessments regarding strictly defined autism, six genome scans were meta-analyzed (Figure 1 ). In the weighted analyses, bin 7.5 (7q22-q32) reached a An additional 60 markers were genotyped in areas selected by the first stage scan. The second stage also included additional families for a total of 38 familes for ASD analyses and 19 families for autism analyses; however, no whole genome data were generated in this expanded sample. b The first number refers to markers used in the whole total sample and the second number to those used in the sample recruited in the first stage of a two stage scan. c Only data on autism spectrum disorders were included in the analyses, since only these were extractable from the graphs in the original report.
genome-wide significance (average rank P ¼ 10 À5 , P ord ¼ 0.0033). Interestingly, the neighboring bin 7.6 (7q32-qter) reached suggestive significance (average rank P ¼ 0.0027) ( Table 2) . A single additional bin (11.2 (11p14-q11)) obtained an average rank with Po0.05 (Table 2; Figure 1 ).
There was also evidence for significant low between-scan heterogeneity for bin 7.5 ( Table 2 ). This was no longer formally significant when the average rank of the bin was taken into account. Bin 7.6 did not have significantly low or high heterogeneity (Table 2) .
In unweighted analyses, bin 7.5 was again identified as being genome-wide significant (average rank P ¼ 0.0002, P ord ¼ 0.0168). Again there was evidence for low between-scan heterogeneity (Po0.018 for all three metrics), but this was lost when the bin's average rank was taken into account. Bin 7.6 did not manage to reach suggestive significance (average rank Figure 1 Weighted average ranks from six autism scans. The average rank for each bin in the weighted analyses is shown. Vertical lines separate autosomes. The horizontal dashed reference line indicates weighted average ranks at the 95% significance level. Empty circles represent bins where no evidence for low between-scan heterogeneity was found with any of the three heterogeneity metrics (unadjusted for the bin's mean rank, at the 0.05 level). Filled circles indicate that evidence for low heterogeneity (unadjusted for the bin's mean rank, at the 0.05 level) was found with all three metrics (black rimblack fill), exactly two out of three metrics (black rim -gray fill), or only one of the three metrics (grey rim -gray fill). Figure 2 ). Another eight bins had Po0.05 for their average rank (Table 2) . Interestingly, among them was bin 17.3 (17q21-q23), the flanking chromosomal region of bin 17.2. There was evidence for high between-scan heterogeneity for bin 17.2 when its average rank was taken into account, for all three heterogeneity metrics (right-sided Po0.05, suggesting high between-scan heterogeneity; Table 2 ). On the contrary, bins 10.2 and 4.1 (4pter-p15.3) had evidence for low between-scan heterogeneity for one of the three metrics, but this was no longer true when their average rank was taken into account ( Table 2 ). There were no bins that reached suggestive significance in the unweighted analyses. There were six bins that reached Po0.05 for their average rank (in order of ascending P-value: 3.5 (3q13.1-q21), 10.2, 4.2 (4p15.2-p11), 10.3 (10q11.2-q21), 2.3 (2p16-p12), 4.1 (4pter-p15.3)). P ord was 40.24 for all of them. There were hints for significantly low heterogeneity only for bin 2.3 (Po0.04 for all three metrics), and only when the average rank of the bin was not taken into account.
Discussion
In this meta-analysis, we synthesized data from nine available genome scans on autism and autism-spectrum disorders. We found that a single chromosomal region in the long arm of chromosome 7 (region q22-q32) reached genome-wide significance for the strict autism definition. All six synthesized genome scans in this analysis were consistent beyond chance in identifying this region among the most promising for linkage with autism. On the other hand, when all autism-spectrum disorders were taken into account, suggestive (less stringent) significance was observed for very different chromosomal regions, namely 17p11.2-q12 and 10p12-q11.1 but with evidence for high between-scan heterogeneity for the former region at least. Given the observed linkage scores of the identified regions across genome scans, very large primary studies would be required to identify them with high certainty in the absence of a meta-analytic approach.
As of this writing, there are no robust documented associations of gene variants with autism. Several polymorphisms in various candidate genes have been probed in several association studies for possible relationship with autism and autism-spectrum disorders. The RELN gene is one of more than a dozen candidate genes that have been examined by molecular analysis. RELN maps to 7q22, in the region that reached genome-wide significance in our meta-analysis. Its product is an extracellular serine protease 36 that affects neuronal migration during central nervous system development. 37 In the mouse model reeler, 38 where the corresponding REELIN gene is mutated, laminar brain structures like the cortex, the cerebellum and the hippocampus are perturbed. 39 Mice homozygous for the defect have less Purkinje cells and exhibit cerebellar hypoplasia, 40 and such anatomic anomalies are identified in autistic people. 41 On the other hand, in autism, lamination defects in both the cortex and cerebellum are not observed, and human Mendelian disorders that affect the RELN system like a variant of lyssencephaly, 42 do not exhibit the neuropsychiatric signs of autism and autism-spectrum disorders. Association studies focusing on a functional variant of the RELN gene, the (GGC)n variable length repeat in the 5 0 untranslated Figure 2 Weighted average ranks from five scans on autism spectrum disorders. Layout similar to Figure 1 .
region before the start codon, have reached conflicting results. [43] [44] [45] [46] [47] [48] [49] This may reflect only the common pattern of nonreplication of early claims from small studies 50 or a modest effect may still be present. A large study should be conducted on this association. 51 It is unknown whether the claimed small effect sizes of the GGC repeat might underlie the consistent linkage signal across the various genome scans. On the other hand RELN is a large gene and there may be still undiscovered variants that more clearly confer risk to autism. RELN is only one of the best studied candidate gene in the region. Studies probing defects in the FOXP2 gene (in the SPCH1 locus, also in the 7q22-q32 region) also reached conflicting results. [52] [53] [54] Less studied genes in the proximity, are CORTBP2 (cortactin-binding protein-2), 55 CADPS2 (Ca 2 þ -dependent activator for secretion) 56 and some others. 57 We should also mention that the linkage peaks of the two largest autism scans in the 7q22-q32 region were observed at the distal part of bin 7.5, close to its border with bin 7.6 (specifically at approximately 147 and 137 cM for the Yonan et al. 24 and Risch et al. scans, respectively), even if the corresponding linkage scores were very marginal (MLS 1.28 and 0.94, respectively). As mentioned above, the flanking chromosomal region 7q32-qter (bin 7.6) also reached suggestive significance. It is not surprising for flanking bins to show significant results, since for complex traits linkage peaks may extend across the borders of two bins. Two previous genome scans, 21, 27 which were excluded from the meta-analysis because they overlapped with one of the included studies, 24 found evidence for linkage in the 7q36 region that belongs to bin 7.6 (this bin also ranked high in the larger study 24 that was included in the analyses). EN2 (homeodomain transcription factor ENGRAILED 2) maps to 7q36.3 and is another candidate gene for autismspectrum disorders. [56] [57] [58] [59] The above results point to the same direction as an older meta-analytic approach that more broadly identified the long arm of chromosome 7 as a region where linkage with autism was more likely to exist. 30 This meta-analysis used a different method to synthesize results across different scans, focused on autism only and utilized much more limited information.
When all autism-spectrum disorders were considered together, suggestive linkage in very different chromosomal regions, namely 17p11.2-q12 and 10p12-q11.1, was reached. Two independent whole genome scans using nonoverlapping Autism Genetic Resource Exchange (AGRE) samples 24, 28 have both identified 17p11.2-q12 as a candidate region. However, this result was not replicated in other genome scans. In fact, we observed significantly high between-scan heterogeneity for this region. This may suggest that autism-spectrum disordered may have a significantly different genetic linkage background across subsyndromes and subpopulations.
Data on candidate genes in the 17p11.2-q12 have also been accumulating. Indirect evidence from a variety of sources suggest that the serotonin transporter gene (5HTT) that is located in the 17q11 region may be a plausible candidate for the genetics of autism-spectrum disorders. Brain imaging studies show that serotonin metabolism is altered in autistic people. 60, 61 Moreover, selective serotonin reuptake inhibitors (a class of antidepressant drugs) may reduce the stereotyped behavior of autistic people, as claimed in uncontrolled studies. 62, 63 There are indications that a known functional polymorphism (5-HTTLPR) may affect the expression of the functionally related but distinct 5-HT1A receptors, offering a plausible pathophysiological mechanism for several mood disorders and behavioral traits. 64 However, studies probing associations of 5-HTTLPR with autism reached conflicting results. [65] [66] [67] [68] The serotonin system is quite diffuse, affecting many different physiological mechanisms, and it may be difficult to assume a pathophysiological pathway specific for autism-spectrum disorders. There are many other genes in this system, and most have not been probed for an association with autism-spectrum disorders.
We should caution that non-significant chromosomal regions in this meta-analysis should not be automatically discarded as irrelevant to autism and autism-spectrum disorders. For example none of the four bins in chromosome 16 reached even suggestive significance in any of the analyses we performed. However, high MLS scores were found for various chromosome 16 regions in some genome scans, 15, 16, 21 and a recent family-based association study claims a role for the protein kinase C-beta gene (PRKCB1) located in 16p) in the etiology of autism. 69 GSMA and HEGESMA can only identify very promising regions examining all available genome scans, in an effort to prioritize research targets.
Meta-analysis of genome scans is one way to trace linkage with a chromosomal region. Another option would be to perform collaborative linkage analyses, analyzing the raw genotypes from scratch in a pooled database. Such a collaborative approach is promising and may have increased power to detect linkage to more narrow chromosomal regions, especially if denser linkage mapping is performed. Such an approach should be encouraged to materialize. However, this approach would not necessarily be immune to biases. It is likely that not all data would be available for unified analyses, and concerns might be raised on whether data are missing at random or systematically. Also, in the presence of genuine heterogeneity among genome scans (for example, if linkage is present only in a specific population), a pooled, nonstratified analysis might not handle adequately linkage signals found only in some studies. In the GSMA framework, such linkage peaks would be more probable to show a signal on the average rank and the extent of heterogeneity between scans can also be probed.
Some potential limitations of our analyses should be taken into account. Results of meta-analyses may be inaccurate if there is publication bias, that is, studies with 'negative' results remain unpublished and studies with strong linkage signals are preferentially dis-seminated in the literature. However, it is unclear whether this would be even an issue in a disease where all genome scans have shown very marginal signals at best. Second, we included data from second stage analyses also. In second stage analyses, additional markers are placed in the regions showing evidence for linkage, and thus, marker density may fluctuate somehow across regions. However, first-and second-stage analyses in the primary genome scan reports were largely similar, and it is unlikely that the identified high ranked bins with low between-scan heterogeneity are an artifact of variable marker density. Allowing for the aforementioned caveats, it is likely that autism susceptibility loci exist in the chromosomal regions we have highlighted and these regions require further scrutiny.
